Immatics NV (IMTX)
9.84
+0.54
(+5.81%)
USD |
NASDAQ |
Mar 31, 16:00
9.83
-0.01
(-0.10%)
After-Hours: 20:00
Immatics EPS Diluted (Quarterly) : -0.3296 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bayer AG | -1.113 |
| MediGene AG | -- |
| InflaRx NV | -0.2115 |
| BioNTech SE | -1.448 |
| CureVac NV | 1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.55M |
| Revenue (Quarterly) | 23.00M |
| Total Expenses (Quarterly) | 64.55M |
| Enterprise Value | 786.66M |
| Profit Margin (Quarterly) | -180.6% |
| Earnings Yield | -18.46% |
| Normalized Earnings Yield | -18.62 |